Maturity onset diabetes of the young (MODY)

Diabetic Medicine

Volumn 13, Issue SUPPL. 6, 1996, Pages

  Fajans, S S ^a,d   Bell, G I ^b   Bowden, D W ^c   Halter, J B ^a   Polonsky, K S ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Genetics of diabetes; Insulin resistance; Insulin secretion; Maturity onset diabetes of the young (MODY)

Indexed keywords

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; MUTATION;

BLOOD GLUCOSE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 7; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GENES, DOMINANT; GENETIC MARKERS; GLUCOKINASE; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; PEDIGREE;

EID: 0029845345     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Fajans SS, Bell GI, Bowden DW. MODY: a model for the study of the molecular gentics of NIDDM. J Lab Clin Med 1992; 119: 206-210.
2. Fajans SS, Bell GI, Bowden DW, et al. Minireview: maturity-onset diabetes of the young. Life Sciences 1994; 55: 413-422.
3. Fajans SS. Maturity-onset diabetes of the young (MODY). Diabetes/Metabolism Reviews 1989; 5: 579-606.
4. Fajans SS. Scope and heterogeneous nature of MODY. Diabetes Care 1990; 13: 49-64.
5. Froguel P, Zoulai H, Vionnet N, et al. Familial hyperglycaemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med 1993; 328: 697-702.
6. Hattersley AT, Turner RC, Permutt MA, et al. Linkage of type 2 diabetes to the glucokinase gene. Lancet 1992; 339: 1307-1310.
7. Velho G, Froguel P Clement K, et al. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindred of maturity onset diabetes of the young. Lancet 1992; 340: 444-448.
8. Bell GI, Xiang K, Newman MC, et al. Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci USA 1991; 88: 1484-1488.
9. Cox NJ, Xian K, Fajans S, et al. Mapping diabetes-susceptibility genes: lessons learned from search for DNA marker for maturity-onset diabetes of the young. Diabetes 1992; 41: 401-407.
10. Bowden DW, Gravius TC, Akots G, et al. Identification of genetic markers flanking the locus for maturity-onset diabetes of the young on human chromosome 20. Diabetes 1992; 41: 88-92.
11. Bowden DW, Akots G, Rothschild CB, et al. Linkage analysis of maturity-onset diabetes of the young (MODY): genetic heterogeneity and non penetrance. Am J Hum Genet 1992; 50: 607-618.
12. Rothschild CB, Akots G, Fajans SS, et al. A microsatellite polymorphism associated with PLC1 (phospholipase C) locus: identification, mapping, and linkage to the MODY locus on chromosome 20. Genomics 1992; 13: 560-564.
13. Rothschild CB, Akots G, Hayworth R, et al. A genetic map of chromosome 20q12-q12.1: multiple highly polymorphic microsatellite and RFLP markers linked to the maturity-onset diabetes of the young (MODY) locus. Am J Hum Genet 1993; 52:110-123.
14. Fajans SS. MODY - a model for understanding the pathogeneses and natural history of type II diabetes. Horm Metabol Res 1987; 19: 591-599.
15. Froguel P, Vaxillaire M, Sun F, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356: 162-164.
16. Stoffel M, Patel P, Loy Y, et al. Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nature Genetics 1992; 2: 153-156.
17. Sakura H, Eto K, Kadowaki H, et al. Structure of the human glucokinase gene and identification of a missense mutation in a Japanese patient with early-onset non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1992; 75: 1571-1573.
18. Shimada F, Makino H, Hashimoto N, et al. Type 2 (non-insulin-dependent) diabetes mellitus associated with a mutation of the glucokinase gene in a Japanese family. Diabetologia 1993; 36: 433-437.
19. Matschinsky F. Glucokinase as glucose sensor and metabolic signal generator in pancreatic β-cells and hepatocytes. Diabetes 1990; 39: 647-652.
20. Vionnet N, Stoffel M, Takeda J, et al. Nonsense mutation in the glucokinase gene cause early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356: 721-722.
21. Stoffel M, Froguel Ph, Takeda J, et al. Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Natl Acad Sci USA 1992; 89: 7698-7702.
22. Sun F, Knebelmann B, Pueyo ME, et al. Deletion of the donor splice site of Intron 4 in the glucokinase gene causes maturity-onset diabetes of the young. J Clin Invest 1993; 92: 1174-1180.
23. Gidh-Jain M, Takeda J, Xu LZ, et al. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci USA 1993; 90: 1932-1936.
24. Vaxillaire M, Vionnet N, Vigouroux C, et al. Search for a third susceptibility gene for maturity-onset diabetes of the young. Diabetes 1994; 43: 389-395.
25. Reaven G, Vernstein R, Davis B, et al. Noketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med 1976; 60: 80-88.
26. Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes 1994; 43: 735-740.
27. Byrne MM, Sturis J, Clement K, et al. Insulin secretory abnormalities in subjects with hyperglycaemia due to glucokinase mutations. J Clin Invest 1994; 93: 1120-1130.
28. De Fronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992; 15: 318-368.
29. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 1988-1992.
30. Herman WH, Fajans SS, Ortiz FJ, et al. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 1994; 43: 40-46.
31. Byrne MA, Sturis J, Fajans SS, et al. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes 1995; 44: 699-704.